NV

Novo Nordisk A/SNYSE NVO Stock Report

Last reporting period 30 Sep, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

65.215

Mega

Exchange

XNYS - New York Stock Exchange, Inc

View Section: Eyestock Rating

Novo Nordisk Fair Value

NV

The fair market value of NVO stock is 98.67 USD. Relative to the market price of 107.5 USD Novo Nordisk is overvalued by 28.9%

Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.

Fair Relative Value

Overvalued 28.9%
98.67 USD
NVO Fair Value
107.5 USD
Market price of NVO

Novo Nordisk Valuation

Current NVO share ticker price is 107.5 USD.

The fair value level of 98.67 USD can be considered as an effective entry point for long-term investors to start investing in NVO stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Current price is 29% higher its fair value

Min value

Current price is 51% higher its minimum value

Max value

Current price is 15% higher its maximum value

20.11.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

NVO stock is overvalued

It means the current price may concern as a Risky Entry Point

Novo Nordisk A/S Stock Valuation Calculator

How do we value a stock?

As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.

1

Maximum P/E over 5 years

32.43

2

Median P/E over 5 years

27.02

3

Minimum P/E over 5 years

18.64

4

Earning per share (last 12 months)

25.79 DKK

Maximum value

1

x

4

=

91.7 USD

Fair value

2

x

4

=

76.41 USD

Minimum value

3

x

4

=

52.7 USD

Novo Nordisk A/S price metrics

30.03

Annual return (geometric mean)

28.37

Risk (standard deviation) of returns

β

0.41

Beta (volatility compared to market)

It means that NVO stock is less volatile than the broader market

Discover Undervalued Companies


View Section: Profitability